Sunday, 19 December 2010
K2 Pedia! | ImmunoGen, Inc. Announces Clinical Data For T-DM1 Used In Combination With Pertuzumab For First-Line Treatment Of HER2+ Metastatic Breast Cancer | Firstline, Pertuzumab, Treatment, Metastatic, Cancer, Breast, Combination, Her+, Used, Immunogen, Clinical, Data, Tdm, Inc, Presentation, Tec http://www.k2pedia.com/breast-cancer/108936-immunogen-inc-announces-clinical-data-for-t-dm1-used-in-combination-with-pertuzumab-for-first-line-treatment-of-her2-metastatic-breast-cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment